pharmacogenetics Flashcards

1
Q

What is pharmacology?

A

The study of drugs, drug action, and metabolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define pharmacogenetics.

A

The study of human genetic variations as revealed by various relations to drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a prodrug?

A

An inactive drug that must be metabolized to the active form to obtain the desired therapeutic effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a xenobiotic?

A

Any foreign compound or chemical that can be absorbed by the human body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What factors influence the response to drugs and prodrugs?

A

Route of administration, Amount of drug absorbed, Drug metabolism (biotransformation), Affinity for endogenous receptors, Elimination of drugs and metabolites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the two phases of drug metabolic reactions?

A

Phase I (functionalization reactions) and Phase II (conjugation reactions).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are Phase I reactions? Give examples.

A

Phase I reactions introduce or remove functional groups. Examples include hydrolysis, reduction, oxidation, deamination, dealkylation, and desulfuration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What enzymes catalyze most Phase I reactions?

A

Cytochrome P-450 (CYP) isoenzymes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are Phase II reactions?

A

Phase II reactions involve conjugation with groups like acetyl, glucuronyl, amino acid, or sulfate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why is pharmacogenetics important clinically?

A

It predicts therapy success or failure, It predicts adverse drug reactions (ADRs) before treatment. It explains differences in drug metabolism and response among patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the two major approaches to predict drug metabolism?

A

Phenotyping and genotyping.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name 7 clinically relevant pharmacogenetic targets.

A
  1. Thiopurine S-Methyltransferase (TPMT),
  2. CYP2C9,
  3. CYP2C19,
  4. CYP2D6,
  5. UDP-Glucuronosyltransferase 1A1 (UGT1A1),
  6. N-Acetyltransferase 1 (NAT1),
  7. N-Acetyltransferase 2 (NAT2).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the role of TPMT?

A

TPMT catalyzes the metabolism of 6-mercaptopurine by methylation and is used to prevent mercaptopurine toxicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is CYP2C9 associated with?

A

CYP2C9 is associated with the metabolism of NSAIDs and warfarin. Polymorphisms can impair warfarin metabolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What drugs are metabolized by CYP2C19?

A

Anticonvulsants, diazepam, propranolol, omeprazole, and proguanil.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the significance of CYP2D6?

A

CYP2D6 metabolizes over 100 drugs and environmental toxins. Its genetic variants affect drug metabolism and dosing.

17
Q

What is the role of UGT1A1?

A

UGT1A1 glucuronidates xenobiotics, increasing their water solubility. Its most important substrate is bilirubin.

18
Q

What do NAT1 and NAT2 do?

A

They catalyze the transfer of acetyl groups to hydrazines and are involved in drug and carcinogen metabolism.

19
Q

How does pharmacogenetics help in personalized medicine?

A

It tailors drug therapy based on an individual’s genetic makeup, optimizing efficacy and minimizing adverse effects.

20
Q

What happens if CYP2C19 is polymorphic?

A

Polymorphisms can affect the activation of prodrugs and the metabolism of specific drugs, altering their effectiveness.

21
Q

Why is TPMT testing important before prescribing 6-mercaptopurine?

A

TPMT testing prevents toxicity by determining if a patient can metabolize the drug safely.

22
Q

What is the clinical significance of UGT1A1 polymorphism?

A

It can lead to hyperbilirubinemia due to impaired bilirubin glucuronidation.